Presenter(s):  Richard Weinshilboum, M.D.

Learning Objectives:

1.  Describe the origins and development of pharmacogenomics from a purely laboratory-based science to an integral aspect of clinical therapeutic decision-making.

2.  Describe the challenges associated with, and the infrastructure required for the clinical implementation of pharmacogenomics.

3.  Describe opportunities created for PGx generally and for CV PGx in particular by the Mayo RIGHT 10K Project.